Skip to main content
. 2024 May 20;43(13):2759–2788. doi: 10.1038/s44318-024-00120-6

Figure 7. TRIM23/HAX1 reduces newly synthesized proteins.

Figure 7

Immunoblot of indicated cells exposed to puromycin (10 μg/ml, 30 min). HEK293T cells transfected with vector or TRIM23 (A), control and TRIM23-overexpressing (TRIM23 o/v) HCT116 cells (B), control and TRIM23 KO HEK293T cells treated with or without oligomycin (1 h) (C), control and TRIM23 KO RKO cells treated with or without oligomycin (1 h) (D), control and HAX1 KO HEK293T cells treated with or without oligomycin (1 h) (E), HAX1 KO HEK293T cells transfected with vector, HAX1WT or HAX1K131R (F), or HAX1 KO HEK293T cells transfected with Flag-HAX1ΔIDR2 or Flag-HAX1ΔIDR2-IDRFUS (G), or with Flag-HAX1K131R or Flag-HAX1K131R-IDRFUS (H) were analyzed for newly synthesized proteins containing puromycin. Source data are available online for this figure.